Risk factors of distant brain failure for patients with newly diagnosed brain metastases treated with stereotactic radiotherapy alone

Radiation Oncology

Volumn 6, Issue 1, 2011, Pages

  Chen, Xiu jun ^a   Xiao, Jian ping ^a   Li, Xiang pan ^a   Jiang, Xue song ^a   Zhang, Ye ^a   Xu, Ying jie ^a   Dai, Jian rong ^a   Li, Ye xiong ^a  

^a CANCER HOSPITAL   (China)

Author keywords

Brain metastasis; Distant brain failure; Stereotactic radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN DYSFUNCTION; BRAIN METASTASIS; BREAST CANCER; CANCER SURVIVAL; CONTROLLED STUDY; DISTANT BRAIN FAILURE; FEMALE; HUMAN; KAPLAN MEIER METHOD; KIDNEY CARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; PROPORTIONAL HAZARDS MODEL; RADIATION DOSE FRACTIONATION; RISK FACTOR; SCORING SYSTEM; STEREOTACTIC BODY RADIATION THERAPY; SURVIVAL TIME; TUMOR VOLUME; BRAIN TUMOR; INCIDENCE; METASTASIS; MIDDLE AGED; MORTALITY; RADIOSURGERY; RETROSPECTIVE STUDY; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; RADIOSURGERY; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 83655191606     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-6-175     Document Type: Article

References (16)

1. Komarnicky LT, Phillips TL, Martz K, et al. A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG 79-16). Int J Radiat Oncol Biol Phys 1991, 20:53-58. 10.1016/0360-3016(91)90137-S, 1993631.
2. Sause WT, Scott C, Kirsch R, et al. Phase I/II trial of accelerated fractionation in brain metastases, RTOG 85-28. Int J Radiat Oncol Biol Phys 1993, 26:653-657. 10.1016/0360-3016(93)90284-3, 8330997.
3. Phillips TL, Scott CB, Leibel S, et al. Results of a randomized comparison of radiotherapy and bromodeoxyuridine to radiotherapy alone for brain metastases: Report of RTOG trial 89-05. Int J Radiat Oncol Biol Phys 1995, 33:339-348. 10.1016/0360-3016(95)00168-X, 7673021.
4. Murray KJ, Scott C, Greenberg HM, et al. A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastasis: A report of RTOG9104. Int J Radiat Oncol Biol Phys 1997, 39:571-574. 10.1016/S0360-3016(97)00341-6, 9336134.
5. Chang EL, Wefel JS, Hess KR, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 2009, 10:1037-44. 10.1016/S1470-2045(09)70263-3, 19801201.
6. Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: A randomized controlled trial. JAMA 2006, 295:2483-2491. 10.1001/jama.295.21.2483, 16757720.
7. Kocher M, Soffietti R, Abacioglu U, et al. Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study. J Clin Oncol 2011, 29(2):134-141. 10.1200/JCO.2010.30.1655, 21041710.
8. Sawrie SM, Guthrie B, Spencer SA, et al. Predictors Of Distant Brain Recurrence For Patients With Newly Diagnosed Brain Metastases Treated With Stereotactic Radiosurgery Alone. Int J Radiat Oncol Biol Phys 2008, 70(1):181-186. 10.1016/j.ijrobp.2007.05.084, 17768015.
9. Radbill AE, Fiveash JF, Falkenberg ET, et al. Initial Treatment of Melanoma Brain Metastases Using Gamma Knife Radiosurgery. Cancer 2004, 101(4):825-833. 10.1002/cncr.20447, 15305416.
10. Lutterbach J, Cyron D, Henne K, Ostertag CB. Radiosurgery followed by planned observation in patients with one to three brain metastases. Neurosurgery 2008, 62(2):776-84.
11. Yu CH, Chen JCT, Apuzzo MLJ, et al. Metastatic Melanoma To The Brain: Prognostic Factors After Gamma Knife Radiosurgery. Int J Radiat Oncol Biol Phys 2002, 52(5):1277-1287. 10.1016/S0360-3016(01)02772-9, 11955740.
12. Matsunaga S, Shuto T, Kawahara N, Suenaga J, Inomori S, Fujino HJ. Gamma Knife surgery for metastatic brain tumors from primary breast cancer: treatment indication based on number of tumors and breast cancer phenotype. Neurosurg 2010, 113(1):65-72.
13. Knisely JPS, Berkey B, Chakravarti A, et al. A Phase III Study Of Conventional Radiation Therapy Plus Thalidomide Versus Conventional Radiation Therapy For Multiple Brain Metastases (RTOG 0118). Int J Radiat Oncol Biol Phys 2008, 71(1):79-86. 10.1016/j.ijrobp.2007.09.016, 18164847.
14. Higuchi Y, Serizawa T, Nagano O, et al. Three-Staged Stereotactic Radiotherapy Without Whole Brain Irradiation For Large Metastatic Brain Tumors. Int J Radiat Oncol Biol Phys 2009, 74(5):1543-1548. 10.1016/j.ijrobp.2008.10.035, 19135317.
15. Aoyama H, Tago M, Kato N, et al. Neurocognitive Function Of Patients With Brain Metastasis Who Received Either Whole Brain Radiotherapy Plus Stereotactic Radiosurgery Or Radiosurgeryalone. Int J Radiat Oncol Biol Phys 2007, 68(5):1388-1395. 10.1016/j.ijrobp.2007.03.048, 17674975.
16. Meyers CA, Wefel JS. The use of the Mini-Mental State Examination to assess cognitive functioning in cancer trials: No ifs, ands, or buts, or sensitivity. J Clin Oncol 2003, 21:3557-3558. 10.1200/JCO.2003.07.080, 12913103.